急性腎不全(急性腎傷害)(Acute Renal Failure)の治療薬パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Acute Renal Failure (ARF) (Acute Kidney Injury) Overview 9
Therapeutics Development 10
Pipeline Products for Acute Renal Failure (ARF) (Acute Kidney Injury) – Overview 10
Pipeline Products for Acute Renal Failure (ARF) (Acute Kidney Injury) – Comparative Analysis 11
Acute Renal Failure (ARF) (Acute Kidney Injury) – Therapeutics under Development by Companies 12
Acute Renal Failure (ARF) (Acute Kidney Injury) – Therapeutics under Investigation by Universities/Institutes 15
Acute Renal Failure (ARF) (Acute Kidney Injury) – Pipeline Products Glance 16
Clinical Stage Products 16
Early Stage Products 17
Unknown Stage Products 18
Acute Renal Failure (ARF) (Acute Kidney Injury) – Products under Development by Companies 19
Acute Renal Failure (ARF) (Acute Kidney Injury) – Products under Investigation by Universities/Institutes 21
Acute Renal Failure (ARF) (Acute Kidney Injury) – Companies Involved in Therapeutics Development 22
ACROVIS biostructures GmbH 22
Adrenomed AG 23
Am-Pharma B.V. 24
Angion Biomedica Corp. 25
Bolder Biotechnology, Inc. 26
Cellmid Limited 27
DiaMedica Inc. 28
Digna Biotech, S.L. 29
F. Hoffmann-La Roche Ltd. 30
G1 Therapeutics, Inc. 31
Hadasit Medical Research Services & Development Ltd 32
Kringle Pharma, Inc. 33
NephroGenex, Inc. 34
Noorik Biopharmaceuticals AG 35
Nyken BV 36
Opsona Therapeutics Ltd. 37
Quark Pharmaceuticals, Inc. 38
STATegics, Inc. 39
Thrasos, Inc. 40
Torrent Pharmaceuticals Limited 41
Acute Renal Failure (ARF) (Acute Kidney Injury) – Therapeutics Assessment 42
Assessment by Monotherapy Products 42
Assessment by Target 43
Assessment by Mechanism of Action 45
Assessment by Route of Administration 47
Assessment by Molecule Type 49
Drug Profiles 51
adrecizumab – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
BB-3 – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
BBT-030 – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
BBT-045 – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
CAB-101 – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
cardiotrophin-1 – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
Cell Therapy to Activate Wnt7b for Kidney Injury – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
CXA-10 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
DM-199 – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
HYPER-IL-6 – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
KP-100IT – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
MTP-131 – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
N-003 – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
NOXD-21 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
NYK-1341 – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
OPN-305 – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
Pyridoxamine Dihydrochloride – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
QPI-1002 – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
R-190 – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
Recombinant Human Alkaline Phosphatase – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
RO-6839328 – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
Small Molecule to Activate Heat Shock Protein 70 (Hsp70) for Delayed Graft Function – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
Small Molecule to Inhibit CDK4 and CDK6 for Acute Kidney Injury and Breast Cancer – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Small Molecule to Inhibit HDAC for Acute Kidney Injury – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
Small Molecules for Acute Renal Failure – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
STSE-15 – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
THR-184 – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
TRC-160334 – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
Acute Renal Failure (ARF) (Acute Kidney Injury) – Recent Pipeline Updates 90
Acute Renal Failure (ARF) (Acute Kidney Injury) – Dormant Projects 102
Acute Renal Failure (ARF) (Acute Kidney Injury) – Discontinued Products 103
Acute Renal Failure (ARF) (Acute Kidney Injury) – Product Development Milestones 104
Featured News & Press Releases 104
Dec 15, 2014: Complexa Initiates Phase 1B Study of CXA-10 in Acute Kidney Injury 104
Nov 13, 2014: AM-Pharma Presents Preclinical Data On Mode-Of-Action For RecAP In Acute Kidney Injury 104
Sep 16, 2014: Thrasos Announces Successful Formal Interim Analysis and Clinical Update for Phase 2 Study of THR-184 for Acute Kidney Injury 105
Jul 01, 2014: Quark Announces Completion of Phase II Trial Evaluating QPI-1002 for Prevention of Delayed Graft Function in Kidney Transplant Patients 106
May 01, 2014: Complexa Initiates First Clinical Trial of CXA-10 for Acute Kidney Injury 106
Mar 26, 2014: AM-Pharma announces positive Phase I data on recAP for Acute Kidney Injury 107
Feb 04, 2014: FDA Grants Thrasos Fast Track Designation for THR-184 in Acute Kidney Injury 107
Jan 28, 2014: American Journal of Kidney Disease publishes review article of Alkaline Phosphatase 108
Nov 08, 2013: AM-Pharma Presents Positive Data from recAP Preclinical Study at ASN Meeting 108
Sep 23, 2013: AM-Pharma Returns to Clinic with Phase I Trial of New Recombinant Human Alkaline Phosphatase to Treat Acute Kidney Injury 109
Appendix 110
Methodology 110
Coverage 110
Secondary Research 110
Primary Research 110
Expert Panel Validation 110
Contact Us 111
Disclaimer 111


【レポート販売概要】

■ タイトル:急性腎不全(急性腎傷害)(Acute Renal Failure)の治療薬パイプライン動向(2015年上半期版)
■ 英文:Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6037IDB
■ 調査対象地域:グローバル
  • 世界のフレグランス市場のM&A動向(2014年6月)
    Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global fragrances market during June 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global fragrances market throughout the month. Additionally, the report provides an overview of all the partn …
  • 中南米のバイオコントロール市場:バイオ殺虫剤、バイオ殺菌剤、バイオ 除草剤、バイオ殺線虫剤
    “Latin America biocontrol market is projected to grow at a CAGR of 15.14%” The Latin America biocontrol market was valued at USD 423.7 million in 2015, and is projected to grow at a CAGR of 16.5%, to reach USD 1,050.7 million by 2021. The market is driven by factors such as increasing awareness regarding biological crop protection products among the farmers in the region, developing economy, risin …
  • Newfield Exploration Company:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Newfield Exploration Company Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Newfield Exploration Company Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
  • デジタルツインの世界市場予測(~2025年)
    “Digital twin market to grow at significant rate from 2019 to 2025” The digital twin market is estimated to grow from USD 3.8 billion in 2019 to USD 35.8 billion by 2025, at a CAGR of 37.8%. Key factors driving the growth of the digital twin market include the declining time and cost of product development and unplanned downtime with the adoption of digital twins, increasing adoption of emerging t …
  • 世界のIPビデオ監視市場:Global IP Video Surveillance Market 2014-2018
    TechNavio's analysts forecast the Global IP Video Surveillance market to grow at a CAGR of 24.89 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in security concerns. The Global IP Video Surveillance market has also been witnessing the increasing demand for high-quality images. However, the lack of standardization could pose a challenge …
  • Top 15 International Integrated Companies – Financial & Operational Fundamental Analysis and Benchmarking-2013
    Top 15 International Integrated Companies - Financial & Operational Fundamental Analysis and Benchmarking-2013 Summary "Top 15 International Integrated Companies - Financial & Operational Fundamental Analysis and Benchmarking-2013" is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of top 15 In …
  • 末梢血管用デバイスの世界市場予測(~2024年)
    “Peripheral vascular devices market to register a CAGR of 6.8% from 2019 to 2024”The peripheral vascular devices market is projected to reach USD 14.4 billion by 2024 from USD 10.3 billion in 2019, at a CAGR of 6.8% during the forecast period. The rapid growth in the geriatric population and the associated increase in the prevalence of peripheral vascular diseases, approval of new and advanced pro …
  • 圧力管理式掘削(MPD)サービス の世界市場:一定坑底圧法(CBHP)、マッドキャップ掘削(MCD)、DGD、RFCD技術
    The global managed pressure drilling services market exhibits a lucrative growth potential of >10% for the next five years. The growth of this market is propelled by the rise in concerns about safety & environment and the increasing capital expenditure in E&P operations being carried out across the globe. The market is further driven by factors such as increasing cost of traditional drilling opera …
  • Sexually-Transmitted Diseases in Japan 2014: Market Outlook and Emerging Opportunities
    About This ReportThis new 280-page report from Venture Planning Group presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.  In addition …
  • 低圧断路器の世界市場動向・予測(~2021)
    The global low voltage disconnect switch market is projected to reach USD 3.51 Billion by 2021 from an estimated value of USD 2.81 Billion in 2016. The growing worldwide transmission and distribution expenditure, growing infrastructural and industrial developmental activities, along with growing safety concerns would propel the market for low voltage disconnect switches. These factors are expected …
  • グローバル通信ビジネス景況感レポート(2015年上半期)
    Summary “Telecom Business Confidence Report H1 2015” is a new report by Pyramid Research that globally analyzes industry opinions on the latest economic and consumer issues, and their impact on investment decisions and growth prospects within the telecom industry. This report also examines executive opinion about the current and future state of the economy and its retrospective effect on the indus …
  • 発電業界のM&A及び投資動向(月別):December 2012
    Power Monthly Deal Analysis - December 2012: M&A and Investment Trends Summary GlobalData's “Power Monthly Deal Analysis - December 2012: M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the power industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture fina …
  • 通気性フィルムの世界市場予測(~2021年):ポリエチレンフィルム、ポリウレタンフィルム、ポリプロピレンフィルム
    The global market size of breathable films is projected to reach USD 3.21 Billion by 2021, registering a CAGR of 7.5%, between 2016 and 2021. The breathable films market is anticipated to register a steady growth in the next five years; it is driven by the growing awareness regarding hygiene and increasing demand of premium hygiene products including baby diapers, sanitary napkins, and adult diape …
  • 生鮮食品の世界市場2017-2021
    About Fresh Food Fresh foods are those that are available in the raw state and have not undergone any form of thermal processing or freezing. Additionally, they are free of preservatives. There is a high demand for such products across the globe as consumers realize the health benefits that these fresh foods offer. Thus, all the major vendors are establishing agreements and partnerships with retai …
  • 神経内分泌がん(Neuroendocrine Carcinoma):世界の治験レビュー(2015年上半期版)
    Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2015" provides data on the Neuroendocrine Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuroendocrine Carcinoma. It includes an overview of the trial num …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。